Literature DB >> 1887253

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

K M Sullivan1, E Agura, C Anasetti, F Appelbaum, C Badger, S Bearman, K Erickson, M Flowers, J Hansen, T Loughran.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1887253

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  167 in total

1.  Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.

Authors:  L Tauchmanovà; C Selleri; M Esposito; C Di Somma; F Orio; G Bifulco; S Palomba; G Lombardi; B Rotoli; A Colao
Journal:  Osteoporos Int       Date:  2003-09-30       Impact factor: 4.507

2.  Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

Authors:  Markus Ditschkowski; Ahmet H Elmaagacli; Rudolf Trenschel; Tanja Gromke; Nina K Steckel; Michael Koldehoff; Dietrich W Beelen
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

3.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

4.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Lauri M Burroughs; Troy R Torgerson; Rainer Storb; Paul A Carpenter; David J Rawlings; Jean Sanders; Andrew M Scharenberg; Suzanne Skoda-Smith; Janet Englund; Hans D Ochs; Ann E Woolfrey
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

5.  Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.

Authors:  Masamichi Isobe; Takaaki Konuma; Masayoshi Masuko; Naoyuki Uchida; Shigesaburo Miyakoshi; Yasuhiro Sugio; Shuro Yoshida; Masatsugu Tanaka; Yoshiko Matsuhashi; Norimichi Hattori; Makoto Onizuka; Nobuyuki Aotsuka; Yasushi Kouzai; Atsushi Wake; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada
Journal:  Ann Hematol       Date:  2021-02-23       Impact factor: 3.673

6.  Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.

Authors:  Ming-Tseh Lin; Barry Storer; Paul J Martin; Li-Hui Tseng; Bryan Grogan; Pei-Jer Chen; Lue P Zhao; John A Hansen
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 7.  Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.

Authors:  M F Siadak; K Kopecky; K M Sullivan
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation.

Authors:  Stefan O Ciurea; Marcos de Lima; Sergio Giralt; Rima Saliba; Carlos Bueso-Ramos; Borje S Andersson; Chitra M Hosing; Srdan Verstovsek; Richard E Champlin; Uday Popat
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-29       Impact factor: 5.742

9.  Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Authors:  Stella Santarone; Andrea Bacigalupo; Antonio M Risitano; Elena Tagliaferri; Erminia Di Bartolomeo; Anna Paola Iori; Alessandro Rambaldi; Emanuele Angelucci; Alessandra Spagnoli; Federico Papineschi; Stefania Tamiazzo; Marta Di Nicola; Paolo Di Bartolomeo
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

10.  Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia.

Authors:  Ming-Huang Chen; Tzeon-Jye Chiou; Peng-Chan Lin; Jyh-Pyng Gau; Hui-Chi Hsu; Liang-Tsai Hsiao; Jin-Hwang Liu; Po-Min Chen
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.